Total Payments
$2,090
2024 Payments
$587.62
Companies
13
Transactions
33
Medicare Patients
5,242
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$1,872 (89.5%)
Education$218.51 (10.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,872 | 23 | 89.5% |
| Education | $218.51 | 10 | 10.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $391.32 | 5 | $0 (2019) |
| Travere Therapeutics, Inc. | $325.68 | 9 | $0 (2024) |
| Baxter Healthcare | $275.93 | 2 | $0 (2024) |
| NxStage Medical, Inc. | $217.18 | 3 | $0 (2018) |
| Mallinckrodt Enterprises LLC | $205.58 | 2 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $125.00 | 2 | $0 (2022) |
| Amgen Inc. | $121.33 | 1 | $0 (2017) |
| Alexion Pharmaceuticals, Inc. | $115.05 | 1 | $0 (2022) |
| Abbott Laboratories | $97.89 | 1 | $0 (2024) |
| Veloxis Pharmaceuticals, Inc. | $95.84 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $587.62 | 10 | Baxter Healthcare ($275.93) |
| 2023 | $136.02 | 3 | Travere Therapeutics, Inc. ($136.02) |
| 2022 | $356.56 | 5 | Aurinia Pharma U.S., Inc. ($125.00) |
| 2021 | $42.94 | 2 | Ultragenyx Pharmaceutical Inc. ($42.94) |
| 2019 | $262.97 | 4 | Otsuka America Pharmaceutical, Inc. ($167.98) |
| 2018 | $315.48 | 4 | Otsuka America Pharmaceutical, Inc. ($223.34) |
| 2017 | $388.90 | 5 | NxStage Medical, Inc. ($142.18) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $97.89 | General |
| Category: Heart Failure | ||||||
| 12/05/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 08/27/2024 | Baxter Healthcare | Renal - Acute (Device) | Food and Beverage | In-kind items and services | $131.32 | General |
| Category: Renal | ||||||
| 08/12/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $136.24 | General |
| 06/19/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $2.38 | General |
| 05/21/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 03/26/2024 | Baxter Healthcare | Renal - Acute (Device) | Food and Beverage | In-kind items and services | $144.61 | General |
| Category: Renal | ||||||
| 03/05/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 02/20/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 01/23/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 11/13/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 10/03/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 08/22/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $129.86 | General |
| 05/17/2022 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 05/12/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | In-kind items and services | $95.84 | General |
| Category: Immunosuppresant | ||||||
| 04/27/2022 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $115.05 | General |
| 02/22/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $105.84 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/22/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/09/2021 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 10/30/2021 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 11/12/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $104.04 | General |
| Category: NEPHROLOGY | ||||||
| 07/22/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 02/18/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Education | In-kind items and services | $2.74 | General |
| Category: NEPHROLOGY | ||||||
| 01/29/2019 | Mallinckrodt Enterprises LLC | ACTHAR (Biological) | Education | In-kind items and services | $94.99 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 10/24/2018 | NxStage Medical, Inc. | System One (Device) | Food and Beverage | Cash or cash equivalent | $75.00 | General |
| Category: Nephrology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,725 | 6,986 | $985,896 | $351,957 |
| 2022 | 15 | 1,350 | 4,710 | $836,688 | $292,864 |
| 2021 | 9 | 1,055 | 3,553 | $779,002 | $274,055 |
| 2020 | 9 | 1,112 | 3,968 | $1.0M | $333,006 |
Total Patients
5,242
Total Services
19,217
Medicare Billing
$1.3M
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 127 | 1,096 | $189,608 | $65,120 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 310 | 565 | $106,220 | $48,446 | 45.6% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 78 | 422 | $105,500 | $37,788 | 35.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 123 | 1,067 | $85,360 | $31,244 | 36.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 145 | 806 | $76,570 | $28,701 | 37.5% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 82 | 824 | $93,112 | $28,498 | 30.6% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 121 | 702 | $70,200 | $24,322 | 34.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 85 | 511 | $76,650 | $23,178 | 30.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 18 | 89 | $50,819 | $18,899 | 37.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 107 | 130 | $63,050 | $16,859 | 26.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 12 | 48 | $32,640 | $12,746 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 93 | 93 | $28,737 | $10,739 | 37.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 333 | 542 | $4,336 | $4,199 | 96.8% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 91 | 91 | $3,094 | $1,218 | 39.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 158 | 1,159 | $200,507 | $62,274 | 31.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 97 | 621 | $155,250 | $48,293 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 278 | 476 | $89,488 | $40,594 | 45.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 19 | 120 | $81,600 | $32,541 | 39.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 131 | 170 | $82,450 | $25,237 | 30.6% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 21 | 76 | $43,396 | $16,366 | 37.7% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2022 | 52 | 521 | $41,680 | $15,863 | 38.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 53 | 334 | $33,400 | $13,150 | 39.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 53 | 322 | $30,590 | $11,922 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $22,248 | $8,321 | 37.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 37 | 150 | $22,500 | $7,194 | 32.0% |
About Dr. John Morris, MD
Dr. John Morris, MD is a Nephrology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235185315.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Morris, MD has received a total of $2,090 in payments from pharmaceutical and medical device companies, with $587.62 received in 2024. These payments were reported across 33 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,872).
As a Medicare-enrolled provider, Morris has provided services to 5,242 Medicare beneficiaries, totaling 19,217 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Memphis, TN
- Active Since 05/26/2006
- Last Updated 03/24/2020
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1235185315
Products in Payments
- Renal - Acute (Device) $275.93
- System One (Device) $217.18
- JYNARQUE (Drug) $215.48
- ACTHAR (Biological) $205.58
- SAMSCA (Drug) $175.84
- LUPKYNIS (Drug) $125.00
- Parsabiv (Biological) $121.33
- CARDIOMEMS (Device) $97.89
- Envarsus (Drug) $95.84
- Crysvita (Drug) $87.75
- KRYSTEXXA (Drug) $17.14
- Rituxan (Biological) $14.80
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Memphis
Dr. Omar Davis, M.d, M.D
Nephrology — Payments: $57,405
Nephrology $57,405
Dr. Natarsha Grant, Md, MD
Nephrology — Payments: $34,340
Nephrology $34,340
Dr. Robert Canada, Md, MD
Nephrology — Payments: $21,903
Nephrology $21,903
Dr. Wael Hussein
Nephrology — Payments: $15,498
Nephrology $15,498
Minesh Pathak, M.d, M.D
Nephrology — Payments: $13,583
Nephrology $13,583
L Quarles, M.d, M.D
Nephrology — Payments: $12,060
Nephrology $12,060